Afuco™ Anti-Human CD63 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CD63 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-CD63 antibodies target a calcium-independent pathway of antigen receptor regulation that is accessible to engagement by membrane proteins and on which novel therapeutic approaches to allergic diseases can be based.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-128CL |
Pricing | Inquiry |
Host | Human |
Target | CD63 |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | ≤6 months at 4°C; ≥6 months at -20°C. |